Endocrine Abstracts

Introduction: The risk of malignancy in thyroid nodules is reported by the Bethesda system by performing fine needle aspiration biopsy (FNAB). Atypia of undetermined significance(AUS) or follicular lesion of undetermined significance(FLUS)(Bethesda 3) and suspicious for a follicular neoplasm (Bethesda 4) create uncertainty about treatment and follow-up. Molecular tests, ultrasonographic features of the nodules, and calcitonin level help us for this uncertainty. Here, we will p...

Introduction: Medullary thyroid cancer (MTC) is characterized by elevated calcitonin levels, stemming from genetic factors or occurring sporadically. Carcinoid syndrome involves symptoms triggered by substances released by tumors, such as hormones and amines. This case report details a patient who developed carcinoid syndrome linked to medullary thyroid cancer.Case: A 77-year-old male presented with flushing, diarrhea, and dizziness. No other health issu...

BackgroundThe risk of cancer is relatively higher in Graves’ patients presenting simultaneously with thyroid nodules. Radioiodine (RAI) therapy recommended in intermediate-high risk differentiated thyroid carcinoma may be associated with worsening of a pre-existing Graves’ orbitopathy (GO) or developing a new onset. The impact of RAI therapy in patients with differentiated thyroid cancer on the course of a pre-exisiting GO has not been specific...